Garland J. Scott insider trades
Garland J. Scott has filed 22 Form 4s with the SEC that we hold, for DAWN (Director), Alx Oncology Holdings INC (ALXO) (Director), Olema Pharmaceuticals, Inc. (OLMA) (Director) and Enliven Therapeutics, Inc. (ELVN) (Director), among 6 companies in all. Across all of them we count 0 purchases worth $0 and 1 sale worth $606.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($606.7K). The largest single trade was a sale of 13,000 shares of Enliven Therapeutics, Inc. worth $606.7K, dated 2026-10-01. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-18 and the latest 2026-10-05.
DAWN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Alx Oncology Holdings INC (ALXO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Olema Pharmaceuticals, Inc. (OLMA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Enliven Therapeutics, Inc. (ELVN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-10-01 | S, sale reported on Form 4 | 13,000 | $606.7K | 2026-10-05 |
Lb Pharmaceuticals INC (LBRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CALA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1533228) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms